MedMesh.i
Corpus
PubMed
Racine
Corpus
Checkpoint
PubMed
Racine
PubMed
Exploration
Accueil
Racine
Racine

La maladie de Parkinson en France (serveur d'exploration) - Corpus (PubMed)

Index « MedMesh.i » - entrée « Dopamine Antagonists »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopamine Agonists < Dopamine Antagonists < Dopamine D2 Receptor Antagonists  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 19.
Ident.Authors (with country if any)Title
000257 (2015) Nicolas Maurice ; Thierry Deltheil ; Christophe Melon ; Bertrand Degos ; Christiane Mourre ; Marianne Amalric ; Lydia Kerkerian-Le GoffBee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease.
000543 (2014) S. Carnicella ; G. Drui ; S. Boulet ; C. Carcenac ; M. Favier ; T. Duran ; M. SavastaImplication of dopamine D3 receptor activation in the reversion of Parkinson's disease-related motivational deficits.
000688 (2013) Jonathan Chetrit ; Anne Taupignon ; Lionel Froux ; Stephanie Morin ; Rabia Bouali-Benazzouz ; Frédéric Naudet ; Nabila Kadiri ; Christian E. Gross ; Bernard Bioulac ; Abdelhamid BenazzouzInhibiting subthalamic D5 receptor constitutive activity alleviates abnormal electrical activity and reverses motor impairment in a rat model of Parkinson's disease.
000694 (2013) Omar Ouachikh ; Wisam Dieb ; Franck Durif ; Aziz HafidiDifferential behavioral reinforcement effects of dopamine receptor agonists in the rat with bilateral lesion of the posterior ventral tegmental area.
000B45 (2009) Stefano Palminteri ; Maël Lebreton ; Yulia Worbe ; David Grabli ; Andreas Hartmann ; Mathias PessiglionePharmacological modulation of subliminal learning in Parkinson's and Tourette's syndromes.
000E28 (2006) Mauricette Brocco ; Anne Dekeyne ; Mariusz Papp ; Mark J. MillanAntidepressant-like properties of the anti-Parkinson agent, piribedil, in rodents: mediation by dopamine D2 receptors.
000F50 (2005) K. Masmoudi ; V. Gras-Champel ; A S Lemaire-Hurtel ; H. Masson ; A. Munier ; J M Geslin ; M. Andréjak[Extrapyramidal adverse effects of veralipride (Agreal), a drug used to treat hot flushes: a propos of 17 cases].
000F88 (2004) Stéphane Thobois ; François Vingerhoets ; Valerie Fraix ; Jing Xie-Brustolin ; Hélène Mollion ; Nicolas Costes ; Patrick Mertens ; Alim-Louis Benabid ; Pierre Pollak ; Emmanuel BroussolleRole of dopaminergic treatment in dopamine receptor down-regulation in advanced Parkinson disease: a positron emission tomographic study.
001011 (2004) Günter U. Höglinger ; Pamela Rizk ; Marie P. Muriel ; Charles Duyckaerts ; Wolfgang H. Oertel ; Isabelle Caille ; Etienne C. HirschDopamine depletion impairs precursor cell proliferation in Parkinson disease.
001055 (2003) A. Courtière ; J. Hardouin ; A. Goujon ; F. Vidal ; T. HasbroucqSelective effects of low-dose dopamine D1 and D2 receptor antagonists on rat information processing.
001076 (2003) S. Thobois ; V. Fraix ; M. Savasta ; N. Costes ; P. Pollak ; P. Mertens ; A. Koudsie ; D. Le Bars ; A L Benabid ; E. BroussolleChronic subthalamic nucleus stimulation and striatal D2 dopamine receptors in Parkinson's disease--A [(11)C]-raclopride PET study.
001100 (2003) Erwan Bézard ; Sandrine Ferry ; Ulrich Mach ; Holger Stark ; Ludovic Leriche ; Thomas Boraud ; Christian Gross ; Pierre SokoloffAttenuation of levodopa-induced dyskinesia by normalizing dopamine D3 receptor function.
001311 (2000) R. Bordet ; S. Ridray ; J C Schwartz ; P. SokoloffInvolvement of the direct striatonigral pathway in levodopa-induced sensitization in 6-hydroxydopamine-lesioned rats.
001420 (1999) S. Chalon ; P. Emond ; S. Bodard ; M P Vilar ; C. Thiercelin ; J C Besnard ; D. GuilloteauTime course of changes in striatal dopamine transporters and D2 receptors with specific iodinated markers in a rat model of Parkinson's disease.
001467 (1998) M G Murer ; G. Dziewczapolski ; L B Menalled ; M C García ; Y. Agid ; O. Gershanik ; R. Raisman-VozariChronic levodopa is not toxic for remaining dopamine neurons, but instead promotes their recovery, in rats with moderate nigrostriatal lesions.
001560 (1996) F. Tison ; L. Wiart ; M. Guatterie ; N. Fouillet ; V. Lozano ; P. Henry ; M. BaratEffects of central dopaminergic stimulation by apomorphine on swallowing disorders in Parkinson's disease.
001658 (1994) M E Llau ; L. Nguyen ; J M Senard ; O. Rascol ; J L Montastruc[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
001769 (1992) W. Rostène ; A. Brouard ; C. Dana ; Y. Masuo ; F. Agid ; M. Vial ; A M Lhiaubet ; D. PelapratInteraction between neurotensin and dopamine in the brain. Morphofunctional and clinical evidence.
001860 (1988) L. Pierot ; C. Desnos ; J. Blin ; R. Raisman ; D. Scherman ; F. Javoy-Agid ; M. Ruberg ; Y. AgidD1 and D2-type dopamine receptors in patients with Parkinson's disease and progressive supranuclear palsy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Corpus

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i -k "Dopamine Antagonists" 

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/MedMesh.i  \
                -Sk "Dopamine Antagonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    indexItem
   |index=    MedMesh.i
   |clé=    Dopamine Antagonists
}}
Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024